Medium materiality6/10
Neurocrine price target raised to $204 from $200 at Needham
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Needham raises NBIX target to $204 from $200; current price $185.5. Modest upside potential.
- Target: $204; Price: $185.5; Firm: Needham
Key facts
- 01
Target: $204
- 02
Posted price: $185.5
- 03
Analyst firm: Needham
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.